Skip to main content

Advertisement

Log in

Serum heat shock protein 27 levels in patients with hepatocellular carcinoma

  • Original Paper
  • Published:
Cell Stress and Chaperones Aims and scope

Abstract

Levels of serum heat shock protein 27 (sHsp27) have been studied in numerous cancer types, but their potential relevance in patients with hepatocellular carcinoma (HCC) is undetermined. Our aim was to compare sHsp27 levels in patients with HCC and HCC-free controls. Specifically, we recruited 71 patients with HCC (80 % with early tumour), 80 patients with chronic liver disease (59 with liver cirrhosis and 21 with chronic active hepatitis) and 42 healthy subjects. sHsp27 was measured by immunoenzymatic assay. Results showed that sHsp27 levels were significantly (p < 0.001) higher in patients with HCC than in the other groups, particularly in those with hepatitis C virus (HCV)-related disease. In HCC patients, sHsp27 levels were not associated with prognostic risk factors, such as size/multiplicity of nodules and stage. In logistic regression analysis, performed in patients with liver disease, log-sHsp27 was associated with a significant age-adjusted 2.5-fold increased odds ratio of HCC and with a significant 4.4-fold higher odds ratio of HCC in the subgroup with HCV-related liver disease. In receiver operating characteristic curve analysis, sensitivity and specificity of the best sHsp27 cut-off value (456.5 pg/ml) for differentiating patients with HCC from those with HCC-free chronic liver disease were 70 and 73 %, respectively. In conclusion, sHsp27 levels are enhanced in patients with HCC and may represent a candidate biomarker of HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • American Liver Tumor Study Group (1998) A randomized prospective multi-institutional trial of orthotopic liver transplantation or partial hepatic resection with or without adjuvant chemotherapy for hepatocellular carcinoma. Investigators Booklet and Protocol. United Network for Organ Sharing. Policy 3.6.4.4

  • Banerjee S, Lin CF, Skinner KA et al (2011) Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression. Cancer Res 71:318–327

    Article  PubMed  CAS  Google Scholar 

  • Bruix J, Sherman M (2005) Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 42:1208–1236

    Article  PubMed  Google Scholar 

  • Calderwood SK, Khaleque MA, Sawyer DB et al (2006) Heat shock proteins in cancer: chaperones of tumorigenesis. Trends Biochem Sci 31:164–172

    Article  PubMed  CAS  Google Scholar 

  • Choi YW, Tan YJ, Lim SG et al (2004) Proteomic approach identifies HSP27 as an interacting partner of the hepatitis C virus NS5A protein. Biochem Biophys Res Commun 318:514–519

    Article  PubMed  CAS  Google Scholar 

  • Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10:86–103

    Article  PubMed  CAS  Google Scholar 

  • De AK, Roach SE (2004) Detection of the soluble heat shock protein 27 (hsp27) in human serum by an ELISA. J Immunoass Immunochem 25:159–170

    CAS  Google Scholar 

  • Delhaye M, Gulbis B, Galand P et al (1992) Expression of 27-kD heat-shock protein isoforms in human neoplastic and nonneoplastic liver tissues. Hepatology 16:382–389

    Article  PubMed  CAS  Google Scholar 

  • El-Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127:S27–S34

    Article  PubMed  Google Scholar 

  • El-Serag HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–2576

    Article  PubMed  CAS  Google Scholar 

  • El-Serag HB, Mason AC, Key C (2001) Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology 33:62–65

    Article  PubMed  CAS  Google Scholar 

  • Fanelli MA, Cuello Carrión FD, Dekker J et al (1998) Serological detection of heat shock protein hsp27 in normal and breast cancer patients. Cancer Epidemiol Biomark Prev 7:791–795

    CAS  Google Scholar 

  • Gruden G, Bruno G, Chaturvedi N et al (2008) Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy. Diabetes 57:1966–1970

    Article  PubMed  CAS  Google Scholar 

  • Howe HL, Wingo PA, Thun MJ et al (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93:824–842

    Article  PubMed  CAS  Google Scholar 

  • Huang Q, Ye J, Huang Q et al (2010) Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma. Clin Chem Lab Med 48:263–269

    Article  PubMed  CAS  Google Scholar 

  • King KL, Li AF, Chau GY et al (2000) Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer 88:2464–2470

    Article  PubMed  CAS  Google Scholar 

  • Lim SO, Park SG, Yoo JH et al (2005) Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules. World J Gastroenterol 11:2072–2079

    PubMed  CAS  Google Scholar 

  • Luk JM, Lam CT, Siu AF et al (2006) Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics 6:1049–1057

    Article  PubMed  CAS  Google Scholar 

  • Mairesse N, Delhaye M, Galand P (1990) Enhanced expression of a 27 kD protein during diethylnitrosamine-induced hepatocarcinogenesis in rats. Biochem Biophys Res Commun 170:908–914

    Article  PubMed  CAS  Google Scholar 

  • Melle C, Ernst G, Escher N et al (2007) Protein profiling of microdissected pancreas carcinoma and identification of HSP27 as a potential serum marker. Clin Chem 53:629–635

    Article  PubMed  CAS  Google Scholar 

  • van Eden W, van der Zee R, Prakken B (2005) Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 5:318–530

    Article  PubMed  Google Scholar 

  • Vidyasagar A, Wilson NA, Djamali A (2012) Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target. Fibrogenesis Tissue Repair 5:7

    Article  PubMed  CAS  Google Scholar 

  • Welsh MJ, Gaestel M (1998) Small heat-shock protein family: function in health and disease. Ann N Y Acad Sci 851:28–35

    Article  PubMed  CAS  Google Scholar 

  • Zimmermann M, Nickl S, Lambers C et al (2012) Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study. Clin Chim Acta 413:1115–1120

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study received grant supports from Piedmont Region “Applied Scientific Research” CIPE and University of Turin.

Conflict of interest

The authors have no conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gabriella Gruden.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gruden, G., Carucci, P., Lolli, V. et al. Serum heat shock protein 27 levels in patients with hepatocellular carcinoma. Cell Stress and Chaperones 18, 235–241 (2013). https://doi.org/10.1007/s12192-012-0377-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12192-012-0377-8

Keywords

Navigation